CARIBOU BIOSCIENCES, INC.

Insiders Caribou Biosciences, Inc.

Equities

CRBU

US1420381089

Market Closed - Nasdaq Other stock markets 01:30:00 16/05/2024 am IST			5-day change	1st Jan Change
3.64 ^USD	0.00%		+4.00%	-36.47%

09/05	Truist Adjusts Price Target on Caribou Biosciences to $19 From $21, Maintains Buy Rating	MT
07/05	Caribou Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Poseida Therapeutics Appoints Syed Rizvi as Chief Medical Officer	26/03	MT
Caribou Biosciences, Inc. Appoints Tim Kelly as Chief Technology Officer	07/01	CI
Syed Rizvi to Leave the Caribou Biosciences, Inc. as Chief Medical Officer, Effective from December 31, 2023	13/12	CI
Caribou Biosciences, Inc. Appoints Sundar Jagannath to its Scientific Advisory Board	06/11	CI
Caribou Biosciences, Inc. Appoints Reigin Zawadzki as Chief People Officer	28/23/28	CI
Caribou Biosciences Announces Appointment of Stephen J. Schuster, MD, to its Scientific Advisory Board	08/23/08	CI
Caribou Biosciences, Inc. Appoints Jason V. O'Byrne as Principal Accounting Officer	17/22/17	CI
Insider Sell: Caribou Biosciences	08/22/08	MT
Insider Sell: Caribou Biosciences	27/22/27	MT
Caribou Biosciences, Inc. Announces Board Changes	19/22/19	CI
Caribou Biosciences, Inc. Appoints David Johnson to its Board of Directors	12/22/12	CI
Caribou Biosciences, Inc. Appoints Syed Rizvi as Chief Medical Officer	18/22/18	CI
Caribou Biosciences, Inc. Announces Management Appointments	08/21/08	CI
Caribou Biosciences Appoints Ran Zheng to its Board of Directors	30/21/30	CI
Caribou Biosciences Appoints Nancy Whiting, Pharm.D., to its Board of Directors	26/21/26	CI
Caribou Biosciences, Inc. Announces Resignation of Jeffrey Long-McGie from the Company's Board of Directors	29/21/29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW